[Chinese expert consensus on diagnosis and treatment of adult early T cell precursor acute lymphoblastic leukemia (2023)].
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2023 Dec 14;44(12):977-982. doi: 10.3760/cma.j.issn.0253-2727.2023.12.002.
Abstract
摘要
相似文献
1
[Chinese expert consensus on diagnosis and treatment of adult early T cell precursor acute lymphoblastic leukemia (2023)].
Zhonghua Xue Ye Xue Za Zhi. 2023 Dec 14;44(12):977-982. doi: 10.3760/cma.j.issn.0253-2727.2023.12.002.
2
[Characteristics and Prognosis in Adult Patients with Early T-Cell Precursor Acute Lymphoblastic Leukemia/Lymphoma from Multicenter].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Feb;32(1):120-124. doi: 10.19746/j.cnki.issn.1009-2137.2024.01.019.
3
[Outcome of 126 adolescent and adult T-cell acute leukemia/lymphoma patients and the prognostic significance of early T-cell precursor leukemia subtype].
Zhonghua Xue Ye Xue Za Zhi. 2019 Jul 14;40(7):561-567. doi: 10.3760/cma.j.issn.0253-2727.2019.07.005.
4
Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia.
Haematologica. 2020 Jun;105(6):e294-e297. doi: 10.3324/haematol.2019.225078. Epub 2019 Sep 19.
5
Early T-Cell Precursor Leukemia: A High-Risk Subtype of Acute Lymphoblastic Leukemia, Single Center Experience in Jordan.
Clin Lymphoma Myeloma Leuk. 2023 Nov;23(11):e411-e419. doi: 10.1016/j.clml.2023.08.007. Epub 2023 Sep 6.
6
Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.
Blood. 2016 Apr 14;127(15):1863-9. doi: 10.1182/blood-2015-08-661702. Epub 2016 Jan 8.
7
Outcomes of adult patients with early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) and non-ETP T-ALL.
Int J Hematol. 2023 May;117(5):738-747. doi: 10.1007/s12185-023-03546-6. Epub 2023 Feb 9.
8
Cytogenetic and molecular characteristics and outcomes of adult patients with early T-cell precursor acute lymphoblastic leukemia.
Eur J Haematol. 2023 Feb;110(2):137-148. doi: 10.1111/ejh.13883. Epub 2022 Oct 18.
9
Short-course Venetoclax With Standard Chemotherapy Is Effective in Early T-cell Precursor Acute Lymphoblastic Leukemia.
J Pediatr Hematol Oncol. 2023 Jul 1;45(5):271-274. doi: 10.1097/MPH.0000000000002672. Epub 2023 Apr 4.
10
Early T-Cell Precursor Leukemia Has a Higher Risk of Induction-Related Infection among T-Cell Acute Lymphoblastic Leukemia in Adult.
Mediators Inflamm. 2020 Dec 23;2020:8867760. doi: 10.1155/2020/8867760. eCollection 2020.
本文引用的文献
1
The Clinical Characteristics and Prognosis of AYA and Older Adult ETP-ALL/LBL: A Real-World Multicenter Study in China.
Front Oncol. 2022 Jun 6;12:846573. doi: 10.3389/fonc.2022.846573. eCollection 2022.
2
Early T-Cell Precursor Acute Lymphoblastic Leukemia: Diagnosis, Updates in Molecular Pathogenesis, Management, and Novel Therapies.
Front Oncol. 2021 Nov 29;11:750789. doi: 10.3389/fonc.2021.750789. eCollection 2021.
3
Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2021 Sep 20;19(9):1079-1109. doi: 10.6004/jnccn.2021.0042.
4
Venetoclax with chemotherapy in relapse/refractory early T-cell precursor acute lymphoblastic leukemia.
Leuk Lymphoma. 2021 Sep;62(9):2292-2294. doi: 10.1080/10428194.2021.1897807. Epub 2021 Mar 10.
5
Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine.
Am J Hematol. 2021 May 1;96(5):589-598. doi: 10.1002/ajh.26144. Epub 2021 Mar 18.
6
Comparison of Early T-Cell Precursor and Non-ETP Subtypes Among 122 Chinese Adults With Acute Lymphoblastic Leukemia.
Front Oncol. 2020 Aug 21;10:1423. doi: 10.3389/fonc.2020.01423. eCollection 2020.
7
Relapsed/refractory early T-cell precursor acute lymphoblastic leukemia was salvaged by venetoclax plus HAG regimen.
Ann Hematol. 2020 Feb;99(2):395-397. doi: 10.1007/s00277-019-03902-9. Epub 2019 Dec 26.
8
Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia.
Leuk Lymphoma. 2020 Apr;61(4):855-861. doi: 10.1080/10428194.2019.1691195. Epub 2019 Nov 22.
9
Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.
Cancer J. 2019 May/Jun;25(3):199-207. doi: 10.1097/PPO.0000000000000376.
10
Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.
Br J Haematol. 2019 Aug;186(4):538-548. doi: 10.1111/bjh.15960. Epub 2019 May 22.
Zotero 插件